Last week, shares of Affymax got hammered when the company pulled back units of its sole commercial drug. Plus, find out what sent the biggest gainers skyward. More
Invest in the Purina Portfolio
Over a span of 32 years, former Ralston Purina CEO Bill Stiritz created tremendous value for shareholders. Here are 10 stocks that have benefited from his legacy -- and could have a place in your portfolio. More
3 Medical Devices Stocks to Sell Now
This week, the overall grades of three Medical Devices stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
The Auto Affordability Roadblock
Despite jumps in sales for most auto companies, the average auto price sits far above the median income of most cities. More
Buy or Sell? The Answer Is Neither
It is sometimes difficult to do nothing, but that is what is called for until the market reveals its next short-term direction. More
Major Hurdle Cleared for TransCanada’s Keystone XL Pipeline
TransCanada Corp. (NYSE:TRP) is trading in a well-defined bull channel, and if the pipeline is approved, shareholders could see substantial gains. More
